Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treatment using human tumor necrosis factor receptor TR17 antibodies

Methods of treatment using human tumor necrosis factor receptor TR17 antibodies

US Patent 7498027 · Granted Mar 3, 2009

Estimated economic value: $2,160,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CSF1R antibody and agonistic anti-CD40 antibody combination therapy for can2023
Methods of treating mesothelioma by administration of compounds comprising FGFR12017
Vascular endothelial growth factor 22016
Albumin fusion proteins2016
Albumin fusion proteins2015
Antibodies that immunospecifically bind to B lymphocyte stimulator protein2015
Albumin fusion proteins2015
Vascular endothelial growth factor 22014
Methods of inhibiting proliferation or immunoglobulin production of B cells usin2013
Methods of inhibiting proliferation or immunoglobulin production of B cells usin2013
Albumin fusion proteins2013
HWBAO62 polypeptides2013